Novo Nordisk reports 10 deaths and 100 hospitalizations from unregulated versions of Ozempic and Wegovy.

Novo Nordisk has reported 10 deaths and 100 hospitalizations linked to unregulated compounded versions of its diabetes and weight-loss drugs, Ozempic and Wegovy. The company has urged the FDA to ban these unauthorized copies, which lack rigorous oversight and are often sold online or through informal channels. Novo Nordisk's CEO expressed concern that patients may mistakenly believe these compounded drugs are safe, as they are not produced by the original manufacturer.

November 06, 2024
37 Articles